Most Popular Stories
- Walgreens plans 100 more retail clinics by mid-2009
- Disruptive doctor behavior causes mistakes, intimidates workers
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- Cleveland Clinic lists potential conflicts of interest online
- HHS: 60 percent of DME companies banned by Medicare may keep billing
Poll
Featured Jobs
-
California Director of Women's Health
StaffPointe, LLC - San Francisco , CA -
California Radialogy Tech Cath Lab
StaffPointe, LLC - Modesto , CA -
Texas Hospitalist
StaffPointe, LLC - south , TX -
Georgia Emergency Medicine
StaffPointe, LLC - southeast coast , GA -
California Urgent Care SLB1197tsNET
StaffPointe, LLC - south , CA
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
- Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
Popular Topics
Feds charge researcher over Pfizer consulting fees
The long arm of the drug companies snags yet another researcher. Pearson "Trey" Sunderland III, who was chief of the Geriatric Psychiatry Branch at the National Institute of Mental Health, is accused of failing to disclose that he accepted $285,000 in consulting and other fees from Pfizer between 1997 and 2004. Sunderland was paid $25,000 a year for consulting with Pfizer and a $2,500 fee for each one-day meeting he attended with Pfizer executives. Sunderland, whose department was working with Pfizer on an effort to identify Alzheimer's biomarkers, potentially faces a year in prison and a $100,000 fine for failing to disclose his financial relationship with Pfizer. At present, he remains an NIH employee but now works as a special assistant and senior adviser.
To learn more about the case:
- check out this report form FierceBiotech
- read this Washington Post piece
Related Articles:
FierceHealthcare readers express their (sometimes heated) opinions on whether gifts and paid dinners from pharma companies are ethically questionable. Letters
Cleveland Clinic to change conflict-of-interest policies. Report
Senate questions NIH conflict-of-interest punishment. Report
Related Stories
- Review boards conflicts of interest are common
- Panel approves Celebrex for children
- Cardiac surgeon faces conflict-of-interest challenge
- Vaccine development surges
- Medicare's needy struggle to get drugs
- Pharmas, device firms spend $182M on lobbying
- NJ AG investigating device maker
- Conflict questions raised in spinal disk study
- Harvard psychiatrists fail to reveal millions in pharma pay
- ALSO NOTED: Google testing medical data storage; Jarvik defends pulled Lipitor ads; and much more...
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





